NDUFB1 and NDUFB2 are associated with altered cardiac energetics and mitochondrial dysfunction in patients with hypertrophic cardiomyopathy, and ROMO1 is an essential redox-dependent regulator of mitochondrial dynamics [30,31]. Here, NDUFB2 is linked to hypertrophic cardiomyopathy.